Immunovant shares owned by Citigroup
Historical chart of Citigroup investment in Immunovant
Tip: Access up to 7 years of quarterly data
All positions including Immunovant held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunovant by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $6.5M | 261k | 24.76 |
| 2024-09-30 | $4.3M | 152k | 28.53 |
| 2024-06-30 | $835k | 32k | 26.42 |
| 2024-03-31 | $8.1M | 250k | 32.30 |
| 2023-12-31 | $5.2M | 124k | 42.11 |
| 2023-09-30 | $4.9M | 126k | 38.43 |
| 2023-03-31 | $5.6M | 363k | 15.51 |
| 2022-12-31 | $1.8M | 103k | 17.75 |
| 2022-09-30 | $17k | 3.0k | 5.75 |
| 2021-12-31 | $1.3M | 155k | 8.52 |
| 2021-03-31 | $3.9M | 243k | 16.04 |
| 2020-12-31 | $834k | 18k | 46.17 |
| 2020-09-30 | $77k | 2.2k | 35.08 |
| 2020-06-30 | $318k | 13k | 24.31 |
| 2020-03-31 | $25k | 1.6k | 15.36 |